Fingerprint
Dive into the research topics of 'A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically